ProShares UltraShort Nasdaq Biotechnology chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A$ (N/A)
Beta N/A
Market capitalization N/A
Operating cash flow N/A
ESG Scores unknown

Company description

Sector: N/A - Industry: N/A


Insider Transactions

Here are the insider transactions of stock shares related to ProShares UltraShort Nasdaq Biotechnology:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to ProShares UltraShort Nasdaq Biotechnology. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on ProShares UltraShort Nasdaq Biotechnology

Here is the result of two systematic investment strategies applied to ProShares UltraShort Nasdaq Biotechnology. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on ProShares UltraShort Nasdaq Biotechnology

The following chart shows the equity curve of the two systematic investment strategies applied to ProShares UltraShort Nasdaq Biotechnology:

ProShares UltraShort Nasdaq Biotechnology automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -54.27% on the backtest period.

Performance at glance

Performance

-54.27 %

Latent gain

-972.76 $

Invested capital

1792.48 $

Annualized return

-13.24 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on ProShares UltraShort Nasdaq Biotechnology

This is the result of two momentum investment strategies applied to ProShares UltraShort Nasdaq Biotechnology. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on ProShares UltraShort Nasdaq Biotechnology

The following chart shows all the entries opened by the momentum investment system on ProShares UltraShort Nasdaq Biotechnology:

ProShares UltraShort Nasdaq Biotechnology momentum entries
  • The first momentum investment strategy would give -52.4% of return on ProShares UltraShort Nasdaq Biotechnology. That represents -2707.29$ of latent gain with 5166.45$ of employed capital.
  • The second momentum investment strategy would give -51.89% of return on ProShares UltraShort Nasdaq Biotechnology. That represents -1988.89$ of latent gain with 3833.26$ of employed capital.
Performance at glance (1Q Momentum)

Performance

-52.4 %

Latent gain

-2707.29 $

Invested capital

5166.45 $

Annualized return

-19.72 %
Performance at glance (2Q Momentum)

Performance

-51.89 %

Latent gain

-1988.89 $

Invested capital

3833.26 $

Annualized return

-14.33 %

Momentum equity curve on ProShares UltraShort Nasdaq Biotechnology

The following chart shows the equity curve of the two momentum strategies applied to ProShares UltraShort Nasdaq Biotechnology:

ProShares UltraShort Nasdaq Biotechnology momentum equity

Note: the dividends potentially given by ProShares UltraShort Nasdaq Biotechnology are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ProShares UltraShort Nasdaq Biotechnology

The following chart shows the employed capital evolution of the two momentum strategies on ProShares UltraShort Nasdaq Biotechnology since the beginning:

ProShares UltraShort Nasdaq Biotechnology

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on ProShares UltraShort Nasdaq Biotechnology

Buy the dip entry openings on ProShares UltraShort Nasdaq Biotechnology

ProShares UltraShort Nasdaq Biotechnology

The performance achieved by the robo-advisor on ProShares UltraShort Nasdaq Biotechnology is -41.42%. That represents -105.36$ of latent gain with 254.4$ of employed capital. The following chart shows ProShares UltraShort Nasdaq Biotechnology stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of ProShares UltraShort Nasdaq Biotechnology, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-41.42 %

Latent gain

-105.36 $

Invested capital

254.4 $

Annualized return

-19.72 %

Equity curve of the strategy applied to ProShares UltraShort Nasdaq Biotechnology

The following chart shows the result of the investment strategy applied to ProShares UltraShort Nasdaq Biotechnology:

ProShares UltraShort Nasdaq Biotechnology

Note: the dividends potentially given by ProShares UltraShort Nasdaq Biotechnology are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on ProShares UltraShort Nasdaq Biotechnology

The following chart shows the employed capital evolution since the beginning of the investment strategy on ProShares UltraShort Nasdaq Biotechnology:

ProShares UltraShort Nasdaq Biotechnology

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on ProShares UltraShort Nasdaq Biotechnology

In this section, I will compare the three previous investment strategies applied to ProShares UltraShort Nasdaq Biotechnology.

Equity curve comparison on ProShares UltraShort Nasdaq Biotechnology

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

ProShares UltraShort Nasdaq Biotechnology investment strategy comparison

Employed capital comparison on ProShares UltraShort Nasdaq Biotechnology

ProShares UltraShort Nasdaq Biotechnology investment comparison

Performance comparison on ProShares UltraShort Nasdaq Biotechnology

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -54.27% -972.76$ 1792.48$ -13.24%
Momentum 1 quarter -52.4% -2707.29$ 5166.45$ -13.58%
Momentum 2 quarters -51.89% -1988.89$ 3833.26$ -14.33%
Non-directional -41.42% -105.36$ 254.4$ -19.72%
Annualized return comparison

Automatic investment

-13.24 %

Momentum 1Q

-14.33 %

Momentum 2Q

-14.33 %

Non-directional

-19.72 %

Correlated stocks

Here are the most positively and negatively correlated stocks with ProShares UltraShort Nasdaq Biotechnology:

Note: The algorithm computes the probability of correlation between ProShares UltraShort Nasdaq Biotechnology and the other stocks. There may be false positives or some missing correlated stocks. If the price of ProShares UltraShort Nasdaq Biotechnology does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name ProShares UltraShort Nasdaq Biotechnology
Country
City
Address
Phone
Website
FullTime employees
Industry
Sector
Exchange XNAS
Ticker BIS
Market www.nasdaq.com

ProShares UltraShort Nasdaq Biotechnology ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown